MEDP
Medpace Holdings, Inc.Healthcare · $17.4B market cap
Verdict
Share price
$599.47
close of Oct 3, 2026
Fair value
$247.44
Sticker Price
Payback Price
$98.97
buy price
MEDP is Overpriced: at $599.47 it trades 142% above its fair value of $247.44. Its buy price (Payback Price) is $98.97, 83% below today's price. Business quality is strong: 4 of 5 key numbers clear the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
4 of 5 clear the 10% bar. What are the Big Five?
Follow MEDP
Get notified when it reaches its buy price of $98.97. Free.
Create a free accountSuperinvestors
4 of the investors we track hold MEDP. In Q2 2026, 2 trimmed. Who we track
Francois Rochon
Giverny Capital · as of Q2 2026
$134.5M
253,931 shares
Vulcan Value Partners
Vulcan Value Partners · as of Q2 2026
$75.1M
141,743 shares
Mairs & Power Funds
Mairs & Power Funds · as of Q2 2026
$45.9M
86,715 shares
Terry Smith
Fundsmith · as of Q2 2026
$27.7M
52,372 shares
Moves in Q2 2026
Trimmed: Terry Smith, Vulcan Value Partners
Insider activity
Since Jun 30, 2026: no open-market purchases, 20 sales worth $82.6M and 8 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Troendle August J.
President & CEO · 2026-08-27
Sold
$403K
Troendle August J.
President & CEO · 2026-08-26
Sold
$2.5M
Kraft Robert O.
director · 2026-08-26
Sold
$2.4M
Troendle August J.
President & CEO · 2026-08-25
Sold
$418K
Troendle August J.
President & CEO · 2026-08-24
Sold
$1.2M
Show all 20 salesShow fewer
Troendle August J.
President & CEO · 2026-08-21
Sold
$8.7M
Troendle August J.
President & CEO · 2026-08-20
Sold
$16.8M
Brady Kevin M.
CFO & Treasurer · 2026-08-20
Sold
$2.1M
DAVENPORT FRED B JR
director · 2026-08-19
Sold
$4.4M
Carley Brian T
director · 2026-08-19
Sold
$3.0M
Troendle August J.
President & CEO · 2026-08-19
Sold
$9.5M
Troendle August J.
President & CEO · 2026-08-13
Sold
$275K
Troendle August J.
President & CEO · 2026-08-12
Sold
$6.8M
Troendle August J.
President & CEO · 2026-08-11
Sold
$10.7M
McCarthy Cornelius P. III
director · 2026-08-11
Sold
$690K
Troendle August J.
President & CEO · 2026-08-10
Sold
$3.3M
McCarthy Cornelius P. III
director · 2026-08-07
Sold
$465K
BURWIG SUSAN E
Exec. VP, Operations · 2026-07-28
Sold
$4.5M
Troendle August J.
President & CEO · 2026-07-28
Sold
$2.1M
Troendle August J.
President & CEO · 2026-07-27
Sold
$2.2M
Other filings
About Medpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV…
Medical - Diagnostics & Research
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works